Dystrophinopathies: Clarification and complication

Journal of Child Neurology

Volumn 11, Issue 1, 1996, Pages 13-20

  Samaha, Frederick J ^a,b   Quinlan, John G ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN;

BECKER MUSCULAR DYSTROPHY; CARDIOMYOPATHY; CHROMOSOME XP; CLINICAL FEATURE; DISEASE CLASSIFICATION; DUCHENNE MUSCULAR DYSTROPHY; GENE MAPPING; GENETIC LINKAGE; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; MUSCLE BIOPSY; MYALGIA; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; REVIEW;

EID: 0030033649     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307389601100103     Document Type: Review

References (63)

1. Engel AG, Yamamoto M, Fischbeck KH: Dystrophinopathies, in Engel AG, Franzini-Armstrong C (eds): Myology: Basic and Clinical. New York, McGraw-Hill, 1994, pp 1133-1187.
2. Greenstein RM, Reardon MP, Chan TS, et al: An (Xp21) translocation in a girl with Duchenne muscular dystrophy. Cytogenet Cell Genet 1980;27:268.
3. Boyd Y, Buckle V, Holt S, et al: Muscular dystrophy in girls with X: Autosome translocations. J Med Genet 1986;23:484-490.
4. Ray PN, Belfall B, Duff C, et al: Cloning of the breakpoint of an Xp21 translocation associated with Duchenne muscular dystrophy. Nature 1985;318:672-675.
5. Kunkel LM, Monaco AP, Middlesworth W: Specific cloning of DNA fragments absent from the DNA of a male patient with an X chromosome deletion. Proc Natl Acad Sci U S A 1985;82: 4778-4782.
6. Hoffman EP, Fischbeck KH, Brown RH, et al: Characterization of dystrophin in muscle biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. N Engl J Med 1988;38:1363-1368.
7. Becker PE: Dystrophia Musculorum Progressive. Stuttgart, Thieme, 1953.
8. Walton JN: On the inheritance of muscular dystrophy. Ann Hum Genet 1955;20:1.
9. Hoffman EP, Schwartz L: Dystrophin and disease. Mol Aspects Med 1991;12:175-194.
10. Hoffman EP, Kunkel LM, Angelini C, et al: Improved diagnosis of Becker muscular dystrophy by dystrophin testing. Neurology 1989;39:1011-1017.
11. Koenig M, Beggs AH, Moyer M, et al: The molecular basis for Duchenne versus Becker muscular dystrophy: Correlation of severity with type of deletion. Am J Hum Genet 1989;45:495-506.
12. Love DR, Aint TJ, Marsden RF, et al: Characterization of deletions in the dystrophin gene giving mild phenotypes. Am J Med Genet 1990;37:136-142.
13. Nicholson LVB, Johnson MA, Bushby KMD, et al: Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 3. Differential diagnosis and prognosis. J Med Genet 1993;30:745-751.
14. Brooke M, Griggs R, Mendell J, et al: Clinical trial in Duchenne dystrophy. 1. The design of the protocol. Muscle Nerve 1981;4: 186-197.
15. Brooke M, Fenichel G, Griggs R, et al: Clinical investigation in Duchenne dystrophy: 2. Determination of the "power" of therapeutic trials based on the natural history. Muscle Nerve 1983;6:91-103.
16. Walton JN, Nattrass FJ: On the classification, natural history and treatment of the myopathies. Brain 1954;77:169-231.
17. Walton J, Gardner-Medwin D: The muscular dystrophies, in Walton J (ed): Disorders of Voluntary Muscle. Edinburgh, Churchill Livingstone, 1988, pp 519-568.
18. Norman A, Thomas N, Coakley J, Harper P: Distinction of Becker from limb-girdle muscular dystrophy by means of dystrophin cDNA probes. Lancet 1989;1:466-468.
19. Arikawa E, Hoffman EP, Kaido M, et al: The frequency of patients with dystrophin abnormalities in a limb-girdle patient population. Neurology 1991;41:1491-1496.
20. Penn AS, Lisak RP, Rowland LP: Muscular dystrophy in young girls. Neurology 1970;20:147-159.
21. Zatz M, Levisky RB, Levy JA, et al: Clinical symptoms in a female carrier of Duchenne muscular dystrophy. J Genet Hum 1973;21:297-305.
22. Moser H, Emery AEH: The manifesting carrier in Duchenne muscular dystrophy. Clin Genet 1974;5:271-284.
23. Meola G, Scarpini E, Silani V, Scarlato G: Manifesting carrier of X-linked Duchenne muscular dystrophy. J Neurol Sci 1981;49:455-463.
24. Yoshioka M: Clinically manifesting carriers in Duchenne muscular dystrophy. Clin Genet 1981;20:6-12.
25. Olson BJ, Fenichel GM: Progressive muscle disease in a young woman with family history of Duchenne's muscular dystrophy. Arch Neurol 1982;39:378-380.
26. Kaladhar Reddy B, Anandavalli TE, Reddi OS: X-linked Duchenne muscular dystrophy in an unusual family with manifesting carriers. Hum Genet 1984;67:460-462.
27. Chutkow JG, Edwards JA, Heffner RR, Czyrny JJ: Monozygotic female twins discordant for the clinical manifestations of Duchenne muscular dystrophy. Neurology 1987;37:1147-1152.
28. Pena SDJ, Karpati G, Carpenter S, Fraser FC: The clinical consequences of X-chromosome inactivation: Duchenne muscular dystrophy in one of monozygotic twins. J Neurol Sci 1987;79: 337-344.
29. Younger DS, Warburton D, Tantravahi U, et al: Monozygous twin carriers of the Duchenne gene: Discordant for clinical myopathy. Neurology 1987;37(Suppl 1):222-223.
30. Royer-Pokora B, Kunkel LM, Monaco AP, et al: Cloning the gene for an inherited human disorder - chronic granulomatous disease - on the basis of its chromosomal location. Nature 1986;322:32-38.
31. Rose CI, Haines DSM: Familial hyperglycerolemia. J Clin Invest 1978;61:163-170.
32. Wirth A, Heuck CC, Bieger W, Schliert G: Pseudo-hypertriglyceridämie bei Glycerokinase-Mangel. Dtsch Med Wochenschr 1985;110:843-847.
33. Hammond J, Howard NJ, Brookwell R, et al: Proposed assignment of loci for X-linked adrenal hypoplasia and glycerol kinase genes. Lancet 1985;1:54.
34. Francke U: Random X inactivation resulting in mosaic nullisomy of region Xp21.1→p21.3 associated with heterozygosity for ornithine transcarbamylase deficiency and for chronic granulomatous disease. Cytogenet Cell Genet 1984;38:298-307.
35. Sunohara N, Arahata K, Hoffman EP, et al: Quadriceps myopathy: Forme fruste of Becker muscular dystrophy. Ann Neurol 1990;28:634-639.
36. Walton JN: Two cases of myopathy limited to the quadriceps. J Neurol Neurosurg Psychiatry 1956;19:106-108.
37. Thage O: The "quadriceps syndrome," an electromyographic and histological evaluation. Acta Neurol Scand Suppl 1965; 13(Suppl 41):245-249.
38. Boddie HG, Stewart-Wynne EG: Quadriceps myopathy - Entity or syndrome? Arch Neurol 1974;31:60-62.
39. Furukawa T, Akagami N, Maruyama S: Chronic neurogenic quadriceps amyotrophy. Ann Neurol 1977;2:528-530.
40. Espir MLE, Matthews WB: Hereditary quadriceps myopathy. J Neurol Neurosurg Psychiatry 1973;36:1041-1045.
41. de Visser M, Bakker E, Defesche JC, et al: An unusual variant of Becker muscular dystrophy. Ann Neurol 1990;27:578-581.
42. Banker BQ, Engel AG: Basic reactions of muscle, in Engel AG, Franzini-Armstrong C (eds): Myology: Basic and Clinical. New York, McGraw-Hill, 1994, pp 857-859.
43. Yunis E, Samaha FJ: Inclusion body myositis. Lab Invest 1971; 25:240-248.
44. Mikol J, Engel AG: Inclusion body myositis, in Engel AG, Franzini-Armstrong C (eds): Myology: Basic and Clinical. New York, McGraw-Hill, 1994, pp 1384-1398.
45. Kuhn E, Fiehn W, Schröder JM, et al: Early myocardial disease and cramping myalgia in Becker-type muscular dystrophy: A kindred. Neurology 1979;29:1144-1149.
46. Gospe SM, Lazaro RP, Lava NS, et al: Familial X-linked myalgia and cramps: A nonprogressive myopathy associated with a deletion in the dystrophin gene. Neurology 1989;39:1277-1280.
47. Hatae T, Yamada T, Kobayashi T, et al: Exercise-induced myalgia and high CKemia with a deletion in the dystrophin gene. Clin Neurol 1991;31:1155-1157.
48. Higuchi I, Nakamura K, Nakagawa M, et al: Steroid-responsive myalgia in a patient with Becker muscular dystrophy. J Neurol Sci 1993;115:219-222.
49. Samaha FJ, Quinlan JG: Myalgia and cramps: Dystrophinopathy with wide-ranging laboratory findings. J Child Neurol 1996;11: 21-24.
50. Collins AL, Leyland KG, Kennedy CR, et al: An inherited dystrophin deletion without muscle weakness. Med Genet 1994;31:505-506.
51. Perloff JK, de Leon AC Jr, O'Doherty D: The cardiomyopathy of progressive muscular dystrophy. Circulation 1966;33:625-648.
52. Casazza F, Brambilla G, Salvato A, et al: Cardiac transplantation in Decker muscular dystrophy. J Neurol 1988;235:496-498.
53. Yazawa M, Ikeda S, Owa M, et al: A family of Decker's progressive muscular dystrophy with severe cardiomyopathy. Eur Neurol 1987;27:13-19.
54. Gold R, Kress W, Meurers D, et al: Becker muscular dystrophy: Detection of unusual disease courses by combined approach to dystrophin analysis. Muscle Nerve 1992;15:214-218.
55. Beggs AH, Hoffman EP, Snyder JR, et al: Exploring the molecular basis for variability among patients with Becker muscular dystrophy: Dystrophin gene and protein studies. Am J Hum Genet 1991;49:54-67.
56. Palmucci L, Doriguzzi C, Mongini T, et al: Dilating cardiomyopathy as the expression of Xp21 Decker type muscular dystrophy. J Neurol Sci 1992;111:218-221.
57. Muntoni F, Cau M, Ganau A, et al: Brief report: Deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N Engl J Med 1993;329:921-925.
58. Michels V: Progress in defining the causes of idiopathic dilated cardiomyopathy. N Engl J Med 1993;329:960-961.
59. Rowland L: Clinical concepts of Duchenne muscular dystrophy. Brain 1988;111:479-495.
60. Richards S, Iannaccone ST: Dystrophin and DNA diagnosis in a large pediatric muscle clinic. J Child Neurol 1994;9:162-166.
61. Dubowitz V: Mental retardation in Duchenne muscular dystrophy, in Rowland LP (ed): Pathogenesis of Human Muscular Dystrophies. Amsterdam, Excerpta Medica, 1977, pp 688-698.
62. Emery AEH, Skinner R, Holloway S: A study of possible heterogeneity in Duchenne muscular dystrophy. Clin Genet 1979;15: 444-449.
63. Colomer J, Gallano P, Nicholson L, et al: Severe mental retardation in a young boy with an in-frame deletion in the dystrophin gene. Eur J Pediatr 1994;153:492-494.